Neonatal management and outcomes of prenatally diagnosed CHDs.

Objectives: The aim of this study was to determine the probability of intervention at birth after prenatal diagnosis of CHD. Methods: A 10-year retrospective study including all foetuses with a prenatally diagnosed CHD and those delivered in a tertiary-care cardiac centre between January, 2002 and December, 2011 was carried out. Patients were classified into eight groups according to the anticipated risk of neonatal intervention. Results: The need for urgent intervention and/or PGE1 infusion within the first 48 hours of life was 47% (n = 507/1080): 72% (n = 248) for CHD at risk for a Rashkind procedure, 77% (n = 72) for CHD with ductaldependent pulmonary flow, 13% (n = 22) for CHD with potentially ductal-dependent pulmonary flow, 94% (n = 62) for CHD with ductal-dependent systemic flow, 29% (n= 88) for CHD with potentially ductaldependant systemic flow, 50% (n= 4) for total anomalous pulmonary venous connection, and 17% (n= 1) for CHD with atrio-ventricular block. In all, 34% of the patients received PGE1 infusion and 21.4% underwent urgent catheter-based or surgical interventions; 10% of patients without anticipated risk (n = 10) underwent an early intervention; 6.7% (n= 73) of the patients died; and 55% (n= 589) had an intervention before discharge from hospital. Conclusion: Half of the neonates with foetal CHD benefited from an urgent intervention or PGE1 infusion at birth. We recommend scheduled delivery and in utero transfer for transposition of the great arteries, double-outlet right ventricle with sub-pulmonary ventricular septal defect, total anomalous pulmonary venous connection, CHD with atrio-ventricular block with heart rate < 50, all ductal-dependant lesions, and CHD with potentially ductal-dependant systemic flow.